journal article·2025-05-07

Direct cGAMP Delivery via Iron Oxide Nanoparticles for Enhanced STING Activation and Durable Antitumor Immunity

Chen Yang, Han Ma, Junli Meng, Jingjiao Li, Haonan Huo, Wei Li, Yuanyuan Zhao, Yixing Wen, Shiwei Mi, Shuai Liu, Xingdi Cheng, Haowei Zu, Simin Sun, Li Ye, Hao Wang, Yayi He, Xueguang Lu, Mingyuan Gao

Nano Letters· Volume 25· Issue 18
Publisher page

Abstract

Activation of the stimulator of interferon genes (STING) pathway holds immense potential for cancer immunotherapy. However, clinical translation of STING agonists such as cyclic GMP-AMP (cGAMP) is hindered by their inherent instability and poor cellular uptake efficacy. Herein, we report an iron oxide nanoparticle (IONP)-based carrier for delivering cGAMP via coordination chemistry. The ribose, phosphate, and adenine on cGAMP were leveraged to directly bind IONP, resulting in cGAMP-functionalized IONPs (Fe-cGAMP). Such a design greatly improved the cellular uptake and STING activation efficacy of cGAMP. Beyond delivery, IONPs promoted reactive oxygen species (ROS) production and activated Toll-like receptors, leading to synergistic immune activation alongside cGAMP. Fe-cGAMP exhibited robust antitumor effects in multiple mouse tumor models. In combination with immune checkpoint inhibitors, Fe-cGAMP could induce complete tumor remission in over 50% of treated mice, and these mice also remain tumor-free upon a subsequent challenge, demonstrating strong and long-lasting antitumor immune responses.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: interferon and immune responses · Nanoplatforms for cancer theranostics · Amoebic Infections and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Beijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Colloid, Interface and Chemical Thermodynamics

Institute of Chemistry, Chinese Academy of Sciences

University of Chinese Academy of Sciences

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute

School of Medicine, Tongji University

Center for Molecular Imaging and Nuclear Medicine, School of Life Sciences & School for Radiological and Interdisciplinary Sciences (RAD-X) & The Second Affiliated Hospital of Soochow University

Soochow University

Funding

National Natural Science Foundation of China · Chinese Academy of Sciences

References (53)

Show source-provided references
1. 10.1038/nri392110.1038/nri3921 ↗
2. 10.1038/nature0731710.1038/nature07317 ↗
3. 10.1016/j.mattod.2024.07.00410.1016/j.mattod.2024.07.004 ↗
4. 10.1016/j.addr.2021.11402010.1016/j.addr.2021.114020 ↗
5. 10.3389/fimmu.2024.148554610.3389/fimmu.2024.1485546 ↗
6. 10.1038/s41565-018-0342-510.1038/s41565-018-0342-5 ↗
7. 10.1038/nchembio.166110.1038/nchembio.1661 ↗
8. 10.1038/s41565-023-01447-710.1038/s41565-023-01447-7 ↗
9. 10.1021/acsnano.0c0276510.1021/acsnano.0c02765 ↗
10. 10.1016/j.jconrel.2017.11.03010.1016/j.jconrel.2017.11.030 ↗
11. 10.1126/sciimmunol.add115310.1126/sciimmunol.add1153 ↗
12. 10.1002/adbi.20160001310.1002/adbi.201600013 ↗
13. 10.1016/j.jconrel.2015.08.02610.1016/j.jconrel.2015.08.026 ↗
14. 10.7150/thno.7101010.7150/thno.71010 ↗
15. 10.1021/acsnano.4c1067310.1021/acsnano.4c10673 ↗
16. 10.1002/adtp.20200013010.1002/adtp.202000130 ↗
17. 10.1021/acsnano.4c0846310.1021/acsnano.4c08463 ↗
18. 10.1016/j.bioactmat.2024.09.00210.1016/j.bioactmat.2024.09.002 ↗
19. 10.1517/17425247.2010.48598310.1517/17425247.2010.485983 ↗
20. 10.1021/jacs.7b0890010.1021/jacs.7b08900 ↗
21. 10.1002/adma.20140015810.1002/adma.201400158 ↗
22. 10.1021/acsnano.5b0499610.1021/acsnano.5b04996 ↗
23. 10.1002/ange.20201434810.1002/ange.202014348 ↗
24. 10.1038/nmat378010.1038/nmat3780 ↗
25. 10.1021/acs.nanolett.6b0426910.1021/acs.nanolett.6b04269 ↗
26. 10.1021/acsnano.7b0267510.1021/acsnano.7b02675 ↗
27. 10.1021/acs.biomac.6b0188510.1021/acs.biomac.6b01885 ↗
28. 10.1016/j.colsurfb.2017.01.01510.1016/j.colsurfb.2017.01.015 ↗
29. 10.1021/acs.molpharmaceut.7b0110310.1021/acs.molpharmaceut.7b01103 ↗
30. 10.1016/j.vaccine.2010.12.03110.1016/j.vaccine.2010.12.031 ↗
31. 10.1016/j.nano.2012.02.01510.1016/j.nano.2012.02.015 ↗
32. 10.1021/acsami.5b0549710.1021/acsami.5b05497 ↗
33. 10.1186/s11671-018-2661-810.1186/s11671-018-2661-8 ↗
34. 10.1038/nnano.2016.16810.1038/nnano.2016.168 ↗
35. 10.1021/jacs.8b1090410.1021/jacs.8b10904 ↗
36. 10.1021/acsnano.3c1206410.1021/acsnano.3c12064 ↗
37. 10.1002/adma.20220991010.1002/adma.202209910 ↗
38. 10.1021/cr068445e10.1021/cr068445e ↗
39. 10.1002/adma.20130474410.1002/adma.201304744 ↗
40. 10.1002/anie.20181073510.1002/anie.201810735 ↗
41. 10.1021/ja108948z10.1021/ja108948z ↗
42. 10.1002/adma.20170109510.1002/adma.201701095 ↗
43. 10.1021/acs.chemrev.8b0073310.1021/acs.chemrev.8b00733 ↗
44. 10.1002/adbi.20160001310.1002/adbi.201600013 ↗
45. 10.1002/smll.20237035310.1002/smll.202370353 ↗
46. 10.1038/s41563-022-01251-z10.1038/s41563-022-01251-z ↗
47. 10.1038/s41551-020-00675-910.1038/s41551-020-00675-9 ↗
48. 10.1002/adhm.20220124010.1002/adhm.202201240 ↗
49. 10.1186/ar271010.1186/ar2710 ↗
50. 10.1186/s13045-020-00916-z10.1186/s13045-020-00916-z ↗
51. 10.1038/s41418-018-0122-710.1038/s41418-018-0122-7 ↗
52. 10.1021/acsnano.4c1020210.1021/acsnano.4c10202 ↗
53. 10.3791/5342410.3791/53424 ↗